To explore the molecular mechanisms by which inulin-supplemented dietary treatment suppressed mammary tumor growth, the protein expression of several epigenetic-modulatory enzymes, including HDAC1, HDAC2, HDAC3, HDAC6, HDAC8, DNMT3a, and DNMT3b, were evaluated. The gene discussed is DNMT3A; the disease is breast cancer.